Cargando…

Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma

BACKGROUND: N-Myc downstream-regulated gene 2 (NDRG2), as a tumor suppressor, has been demonstrated to inhibit tumor invasion and migration of hepatocellular carcinoma (HCC) by reducing the expression of CD24, which has been identified as a prognostic factor for HCC patients. However, the clinical s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bing, Shao, Qing, Ji, Dong, Li, Fan, Guo, Xiaodong, Chen, Guofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212122/ https://www.ncbi.nlm.nih.gov/pubmed/25338637 http://dx.doi.org/10.1186/s13000-014-0209-5

Ejemplares similares

A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma
por: Zhang, Shu-Wen, et al.
Publicado: (2022)

Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Takuma, Yoshitaka, et al.
Publicado: (2017)

Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival
por: Gardini, Andrea Casadei, et al.
Publicado: (2018)

FAM83D is associated with gender, AJCC stage, overall survival and disease-free survival in hepatocellular carcinoma
por: Liu, Xuling, et al.
Publicado: (2019)

CD24 and Nanog expression in Stem Cells in Glioblastoma: Correlation with Response to Chemoradiation and Overall Survival
por: Soni, Priyanka, et al.
Publicado: (2017)

Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials
por: Li, Yuanfang, et al.
Publicado: (2023)

Prognostic and biological role of the N-Myc downstream-regulated gene family in hepatocellular carcinoma
por: Yin, Xin, et al.
Publicado: (2022)

Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma
por: Cabibbo, Giuseppe, et al.
Publicado: (2020)

Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients
por: Lee, Sang-Jeon, et al.
Publicado: (2013)

Oncogenic Roles of RAD51AP1 in Tumor Tissues Related to Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma
por: Zhuang, Liping, et al.
Publicado: (2020)

m7G Methylation-Related Genes as Biomarkers for Predicting Overall Survival Outcomes for Hepatocellular Carcinoma
por: Li, Xin-Yu, et al.
Publicado: (2022)

Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival
por: Ma, Lidi, et al.
Publicado: (2022)

Polymorphism in asparagine synthetase is associated with overall survival of hepatocellular carcinoma patients
por: Li, Wei, et al.
Publicado: (2017)

Progression-free or overall survival…revisited in BOLERO-2
por: Gupta, Sudeep
Publicado: (2014)

N-Myc downstream-regulated gene 2 suppresses the proliferation of T24 human bladder cancer cells via induction of oncosis
por: HUANG, JIE, et al.
Publicado: (2015)

Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection
por: Wang, Tao, et al.
Publicado: (2020)

N-myc downstream-regulated gene 1: Diverse and complicated functions in human hepatocellular carcinoma (Review)
por: SONG, YAN, et al.
Publicado: (2013)

Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

Factors associated with ethnical disparity in overall survival for patients with hepatocellular carcinoma
por: Li, Juan, et al.
Publicado: (2017)

Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST
por: Lu, Hsiang-Chih, et al.
Publicado: (2018)

VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma
por: Zhang, Ming, et al.
Publicado: (2018)

Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer
por: Beauchemin, Catherine, et al.
Publicado: (2014)

Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients
por: Tejerizo-García, Álvaro, et al.
Publicado: (2013)

Prognostic Factors of Atypical Meningioma: Overall Survival Rate and Progression Free Survival Rate
por: Lee, Jae Ho, et al.
Publicado: (2017)

The prediction models for postoperative overall survival and disease‐free survival in patients with breast cancer
por: Shigemizu, Daichi, et al.
Publicado: (2017)

Prognostic Factors Affecting Disease-Free Survival and Overall Survival in T4 Colon Cancer
por: Eom, Taeyeong, et al.
Publicado: (2021)

Artificial intelligence method to predict overall survival of hepatocellular carcinoma
por: Simsek, Cem, et al.
Publicado: (2021)

Fibrinogen-to-albumin ratio predicts overall survival of hepatocellular carcinoma
por: Sun, Hao, et al.
Publicado: (2023)

Identification of a five-gene signature in association with overall survival for hepatocellular carcinoma
por: Yang, Lei, et al.
Publicado: (2021)

GDF11 upregulation independently predicts shorter overall-survival of uveal melanoma
por: Liu, Xun, et al.
Publicado: (2019)

Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma
por: Liu, Shuang, et al.
Publicado: (2021)

Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
por: Liu, Hua, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio predicts overall survival of patients with combined hepatocellular cholangiocarcinoma
por: He, Chaobin, et al.
Publicado: (2018)

Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma
por: Zhou, Xiaohan, et al.
Publicado: (2021)

Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials
por: Wang, Zi-Xian, et al.
Publicado: (2021)

Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
por: Cicero, Giuseppe, et al.
Publicado: (2018)

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer
por: Varkaris, Andreas, et al.
Publicado: (2019)

MRPL27 contributes to unfavorable overall survival and disease-free survival from cholangiocarcinoma patients
por: Zhuang, Liping, et al.
Publicado: (2021)

A Systematic Review on Overall Survival and Disease-Free Survival Following Total Pelvic Exenteration
por: Miri, Seyed Rouhollah, et al.
Publicado: (2022)

Erratum to “Prognostic factors affecting disease-free survival and overall survival in T4 colon cancer”
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m6qdj9ok1peggu5jmiutgb7q51